ArticleEuropean journal of medicinal chemistry2021

A biphenyl inhibitor of eIF4E targeting an internal binding site enables the design of cell-permeable PROTAC-degraders.

Patrick D Fischer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.